Sitemap > Breaking Research > Diagnostics & Devices
Displaying 751 - 800 of 1058 results
- Development and evaluation of a sensitive enzyme-linked oligonucleotide-sorbent assay for detection of polymerase chain reaction-amplified hepatitis C virus of genotypes 1-6.
- Rabbit monoclonal antibodies show higher sensitivity than mouse monoclonals for estrogen and progesterone receptor evaluation in breast cancer by immunohistochemistry.
- Interleukin-6 and procalcitonin in children with sepsis and septic shock.
- Late and very late stent thrombosis following drug-eluting stent implantation in unprotected left main coronary artery: a multicentre registry.
- A novel method for rapid detection of Streptococcus pneumoniae antigen in sputum and its application in adult respiratory tract infections.
- ISG15 as a novel tumor biomarker for drug sensitivity.
- Meta-analysis shows similar risk of thrombosis after drug-eluting stent, bare-metal stent, or angioplasty.
- Fatty acid-binding protein as marker for renal injury.
- Kidney Injury Molecule-1 (KIM-1): a specific and sensitive biomarker of kidney injury.
- Accuracy assessment of global and local atrophy measurement techniques with realistic simulated longitudinal Alzheimer's disease images.
- Utility of DNA microarrays for detection of viruses in acute respiratory tract infections in children.
- Nucleosomes and CYFRA 21-1 indicate tumor response after one cycle of chemotherapy in recurrent non-small cell lung cancer.
- Changes in bone markers after once-weekly low-dose alendronate in postmenopausal women with moderate bone loss.
- Imaging breast cancer cells and tissues using peptide-labeled fluorescent silica nanoparticles.
- Fabrication and biofunctionalization of selenium-polypyrrole core-shell nanoparticles for targeting and imaging of cancer cells.
- Non-invasive, ultra-sensitive, high-throughput assays to quantify rare biomarkers in the blood.
- CD5 expression is potentially predictive of poor outcome among biomarkers in patients with diffuse large B-cell lymphoma receiving rituximab plus CHOP therapy.
- Aberrant methylation of CXCL12 in non-small cell lung cancer is associated with an unfavorable prognosis.
- Novel Role for RGS1 in Melanoma Progression.
- Atorvastatin prevents atrial fibrillation in patients with bradyarrhythmias and implantation of an atrial-based or dual-chamber pacemaker: a prospective randomized trial.
- One-year clinical outcome after abciximab bolus-only compared with abciximab bolus and 12-hour infusion in the Randomized EArly Discharge after Transradial Stenting of CoronarY Arteries (EASY) Study.
- Correlates of late and very late thrombosis of drug eluting stents.
- Applications of novel monoclonal antibodies specific for synuclein-gamma in evaluating its levels in sera and cancer tissues from colorectal cancer patients.
- Evaluation of N (epsilon)-(3-formyl-3,4-dehydropiperidino)lysine as a novel biomarker for the severity of diabetic retinopathy.
- Pharmacotherapy of PTSD in the U.S. Department of Veterans Affairs: Diagnostic- and Symptom-Guided Drug Selection.
- Prediction of Survival in Multiple Myeloma Based on Gene Expression Profiles Reveals Cell Cycle and Chromosomal Instability Signatures in High-Risk Patients and Hyperdiploid Signatures in Low-Risk Patients: A Study of the Intergroupe Francophone du Myelome.
- Early chemotherapy response evaluation in tumors by 99mTc-DTPA-DG.
- Effective radiotherapy of primary tumors and metastasis with 18F-2-deoxy-2-fluoro-D-glucose in C57BL/6 mice.
- Functional genomics identifies ABCC3 as a mediator of taxane resistance in HER2-amplified breast cancer.
- The humoral immune system has a key prognostic impact in node-negative breast cancer.
- Molecular subtypes of breast cancers detected in mammography screening and outside of screening.
- Osteopontin and Interleukin-8 Expression is Independently Associated with Prostate Cancer Recurrence.
- Persistent Aberrations in Circulating DNA Integrity after Radiotherapy Are Associated with Poor Prognosis in Nasopharyngeal Carcinoma Patients.
- In vivo Optical Molecular Imaging of Vascular Endothelial Growth Factor for Monitoring Cancer Treatment.
- Expression of AT1 and AT2 angiotensin receptors in astrocytomas is associated with poor prognosis.
- Development and preclinical characterisation of (99m)Tc-labelled Affibody molecules with reduced renal uptake.
- Serum and tissue biomarkers as predictive and prognostic variables in epithelial ovarian cancer.
- Soluble CD22 as a tumor marker for hairy cell leukemia.
- Alternative antibody for the detection of CA125 antigen: a European multicenter study for the evaluation of the analytical and clinical performance of the Access((R)) OV Monitor assay on the UniCel((R)) DxI 800 Immunoassay System.
- Alternative antibody for the detection of CA19-9 antigen: a European multicenter study for the evaluation of the analytical and clinical performance of the Access((R)) GI Monitor assay on the UniCel((R)) DxI 800 Immunoassay System.
- Alternative antibody for the detection of CA15-3 antigen: a European multicenter study for the evaluation of the analytical and clinical performance of the Access((R)) BR Monitor assay on the UniCel((R)) DxI 800 Immunoassay System.
- Comparison of the Abbott Realtime HIV-1 and HCV viral load assays with commercial competitor assays.
- Human papillomavirus E6/E7 mRNA testing as a predictive marker for cervical carcinoma.
- Contrast-Enhanced MR Imaging of Brain Lesions: A Large-Scale Intraindividual Crossover Comparison of Gadobenate Dimeglumine versus Gadodiamide.
- Usefulness of (201)TlCl/ (123)I-BMIPP dual-myocardial SPECT for patients with non-ST segment elevation myocardial infarction.
- Histopathological findings in extended prostate biopsy with PSA
- Rapid detection of the hepatitis B virus YMDD mutant using TaqMan-minor groove binder probes.
- Comparison of stent thrombosis, myocardial infarction, and mortality following drug-eluting versus bare-metal stent coronary intervention in patients with diabetes mellitus.
- Randomized, Controlled Trial of Coronary Artery Bypass Surgery Versus Percutaneous Coronary Intervention in Patients With Multivessel Coronary Artery Disease. Six-Year Follow-Up From the Stent or Surgery Trial (SoS).
- MDM2 mRNA Expression in the p53 Pathway May Predict the Potential of Invasion and Liver Metastasis in Colorectal Cancer.